# Task A11: In vitro screening for antifungal activity against fungal disease pathogens

> **NIH NIH N01** · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2020 · $54,896

## Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 10206787
- **Project number:** 75N93019D00022-0-759302000002-1
- **Recipient organization:** UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- **Principal Investigator:** SWEE TEO
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $54,896
- **Award type:** —
- **Project period:** 2020-06-25 → 2021-06-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10206787

## Citation

> US National Institutes of Health, RePORTER application 10206787, Task A11: In vitro screening for antifungal activity against fungal disease pathogens (75N93019D00022-0-759302000002-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10206787. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*